For years, digital therapeutics (DTx) companies assumed the only path to scale was through insurance reimbursement with CPT codes. But in 2026, the most pragmatic route for many self-funded DTx startups is selling to employers directly—bypassing the tangled web of payer politics entirely. This playbook explains how to land those contracts without ever needing a CPT code. The opportunity is not hypothetical: self-insured employers control nearly two-thirds of commercially insured lives in the US, and they are desperate for solutions that lower spend and improve workforce health. The catch? They don’t speak the language of medical billing. They speak the language of ROI, engagement, and retention.
Why Self-Funded Employers Are the New DTx Buyers
Self-funded employers already pay for healthcare claims out of pocket. Unlike fully insured plans, they see every dollar spent on hospital visits, prescriptions, and chronic disease management. This transparency creates an urgent incentive to adopt interventions that demonstrably reduce costly downstream events. DTx products—whether for mental health, diabetes, hypertension, or musculoskeletal pain—fit this need perfectly. But traditional go-to-market models tied to CPT codes force DTx vendors into payer fee schedules, prior authorization quagmires, and coverage decisions that can take years. Employers don’t need that infrastructure. They need a procurement process that resembles buying software, not signing up a new hospital department.
In the self-funded employer context, the buyer is often the benefits director or a consultant at a large brokerage. These stakeholders care about one thing: does this solution actually save money while improving outcomes for a specific population? That question bypasses the entire CPT code conversation. Instead of billing per session or per claim, you negotiate a flat per-member-per-month (PMPM) fee or a project-based pilot. The contract is B2B, not insurance. This is the core mental shift every DTx founder must make.
What Replaces CPT Codes in a Direct Employer Contract?
When CPT codes vanish, your pricing architecture must be rebuilt around value metrics. Employers are familiar with SaaS pricing, and DTx is increasingly treated as an employee benefit technology. That means you need to decide how you’re getting paid: PMPM for the entire eligible population, tiered pricing based on utilization thresholds, or an outcomes-based agreement with a baseline and bonus structure.
The most successful 2026 DTx employer contracts are tied to three categories of measurable outcomes:
- Clinical improvement markers – blood pressure reduction, PHQ-9 depression scores, HbA1c levels, or medication adherence rates.
- Cost reduction claims – reduced ER visits, avoided specialist referrals, or lower prescription spend for alternative drugs.
- Engagement and completion rates – because a low-quality program with high engagement still outperforms a high-quality program nobody uses.
These metrics replace the need to justify clinical efficacy to a payer’s medical review board. Instead, you present a performance dashboard to the employer’s benefits committee. That dashboard becomes your CPT code—a quantifiable, auditable link between your product and their bottom line.
The Employer Pitch: Outcomes, ROI, and Engagement
Forget the typical DTx pitch deck full of clinical trial results from academic journals. For most employers, the strongest argument is a blended model: clinical data supports credibility, but financial modeling closes the deal. You need to show an employer how many diabetics, hypertensive employees, or workers with anxiety and depression they likely have in their workforce. Then you estimate the annual claim cost for each untreated member. Your DTx product is the lever that reduces that cost by a predictable percentage.
A practical approach is to run a limited pilot with one workforce location or a single claims data set. Offer to price the pilot so the employer’s maximum downside is a few months of PMPM fees. In return, you ask for access to aggregate claims data to refine your ROI estimate. This is not a classic insurance arrangement—it’s a vendor-client data collaboration. Employers love this because it feels like procurement, not a clinical trial.
Engagement is the next critical part of the pitch. A self-funded employer does not care what your app can do in a vacuum. They care whether their employees will open it, use it, and stick with it for the prescribed duration. In 2026, smart DTx companies hardwire engagement features like human coaching, gamification, and wearable integrations into the employer-facing value proposition. You are selling a workflow, not just an app.
Legal and Data-Sharing Considerations for Direct B2B DTx
Skipping CPT codes does not mean skipping compliance. When you contract directly with an employer, you’re entering a data-sharing relationship that must comply with HIPAA, applicable state privacy laws, and the emerging patchwork of employee consent requirements. You are not a covered entity in the traditional sense, but you will likely become a business associate of the employer’s health plan. That means you need a solid business associate agreement (BAA) and a clear data governance framework.
Another key legal nuance: avoid making explicit health outcome guarantees that could be interpreted as medical advice or a promise to alter benefit plan design. Instead, frame your outcomes-based bonuses around measured improvements in validated scores or utilization data. This protects both sides. Also, consider whether your product needs FDA clearance or is sold as a wellness tool. If it is a legitimate DTx with clinical evidence, employers will care more about its evidence grade than its regulatory status—but your legal team should still clarify the difference between a medical device and a wellness benefit under ERISA and the Affordable Care Act.
Working with a benefits consultant is often essential here. Consultants understand the actuarial data, the ERISA compliance requirements, and the connection between employee health and total rewards. In many cases, the consultant is the gatekeeper who convinces a mid-sized employer to take a chance on an innovative DTx vendor. Invest in educational materials that make it easy for a consultant to say yes.
A 6-Step Playbook for Your First Employer Contract
Without CPT codes or a payer relationship, your sales process must be disciplined and fast. The following six steps have proven effective for self-funded DTx companies in 2026.
Step 1: Narrow Your Buyer Profile
Do not pitch every employer. Focus on self-funded organizations with at least 500 employees, a broker or consultant who is forward-thinking, and a workforce with demographic profiles that map to your product. For instance, a mental health DTx should target industries like logistics, manufacturing, or healthcare itself—sectors with high stress and high turnover.
Step 2: Build a Claims-Informed Value Story
Use published claims data or anonymized employer data to build a pro-forma ROI model. Show the cost per responder, the break-even point, and the projected annual savings for the employer’s specific population. This is the direct replacement for a CPT fee schedule.
Step 3: Price as a Service, Not a Billing Code
Offer a simple, transparent pricing table. PMPM rates or fixed annual licenses work best. Avoid any language that resembles per-claim or per-procedure billing. Employers expect annual contracts with clear renewal conditions, much like a benefits admin platform.
Step 4: Run a Rapid 90-Day Pilot
A pilot is your proof, not your clinical trial. Recruit 100-200 employees, set a measurable target (e.g., 80% weekly engagement or an average PHQ-9 reduction of 4 points), and share weekly progress dashboards. The pilot should feel like an Agile sprint, not a peer-reviewed study. Be prepared to adjust the product based on employee feedback quickly.
Step 5: Co-Craft the Outcomes Bonus
For the full rollout, propose an upside bonus if you hit pre-agreed clinical and cost-reduction thresholds. This signals confidence and aligns incentives. Many self-funded employers appreciate this because it turns the DTx vendor into a risk-sharing partner, which is far more compelling than a traditional vendor relationship.
Step 6: Plan the Post-Employer Expansion
Once you have two or three employer contracts, your data becomes an asset. Aggregate outcomes (with proper de-identification) can be used to negotiate broader partnerships with benefits platforms or self-insured coalitions. You still don’t need CPT codes, but your proof of value will eventually attract payers on your own terms.
Bringing It Together
Self-funded DTx sales without CPT codes is not a compromise. It is a strategic choice that aligns your product with the modern employer’s value-driven mindset. By reshaping your pricing, your metrics, and your sales motion around direct B2B relationships, you can sidestep payer bureaucracy and generate revenue in months, not years. The employers are already looking for better answers. Your job is to hand them a contract, a dashboard, and a clear path to lower healthcare costs—no billing codes required.
